AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 1 filers reported holding AQUINOX PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $9,000 | -88.2% | 3,637 | -87.1% | 0.01% | -84.8% |
| Q1 2019 | $76,000 | -56.1% | 28,300 | -64.8% | 0.03% | -62.9% |
| Q4 2018 | $173,000 | +4.2% | 80,289 | +41.7% | 0.09% | -4.3% |
| Q3 2018 | $166,000 | -84.4% | 56,650 | -85.9% | 0.09% | -88.1% |
| Q2 2018 | $1,062,000 | – | 400,900 | – | 0.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 877,753 | $14,492,000 | 5.61% |
| RA Capital Management | 2,191,977 | $36,190,000 | 5.13% |
| Opaleye Management Inc. | 310,000 | $5,118,000 | 3.02% |
| EMORY UNIVERSITY | 143,691 | $2,372,000 | 2.34% |
| Baker Brothers Advisors | 10,536,092 | $173,951,000 | 1.70% |
| Ghost Tree Capital, LLC | 225,000 | $3,715,000 | 0.89% |
| Cormorant Asset Management, LP | 151,838 | $2,507,000 | 0.34% |
| Eventide Asset Management | 175,000 | $2,889,000 | 0.19% |
| JGP Global Gestao de Recursos Ltda. | 11,380 | $188,000 | 0.10% |
| Virtus ETF Advisers LLC | 16,347 | $270,000 | 0.08% |